A genetic IFN/STAT1/FAS axis determines CD4 T stem cell memory levels and apoptosis in healthy controls and Adult T-cell Leukemia patients

References

• Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50(3):481–92. PMID:301762.
   PubMed Web of Science ®Google Scholar
• Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci United States Am. 1980;77(12):7415–9. doi: 10.1073/pnas.77.12.7415.
   PubMed Web of Science ®Google Scholar
• Verdonck K, González E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis. 2007;7(4):266–81.doi: 10.1016/S1473-3099(07)70081-6 PMID:17376384.
   PubMed Web of Science ®Google Scholar
• Cleghorn FR, Manns A, Falk R, Hartge P, Hanchard B, Jack N, Williams E, Jaffe E, White F, Bartholomew C, et al. Effect of human T-lymphotropic virus type I infection on non-Hodgkin's lymphoma incidence. J Natl Cancer Inst. 1995;87(13):1009–14. doi:10.1093/jnci/87.13.1009. PMID:7629870.
   PubMedGoogle Scholar
• Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol. 1991;79(3):428–37. doi:10.1111/j.1365-2141.1991.tb08051.x. PMID:1751370.
   PubMed Web of Science ®Google Scholar
• Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington W, Jr, O'Mahony D, Janik JE, Bittencourt AL, Taylor GP, et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol. 2009;27(3):453–9. doi:10.1200/JCO.2008.18.2428. PMID:19064971.
   PubMed Web of Science ®Google Scholar
• Bittencourt AL, da Graças Vieira M, Brites CR, Farre L, Barbosa HS. Adult T-cell leukemia/lymphoma in Bahia, Brazil: analysis of prognostic factors in a group of 70 patients. Am J Clin Pathol. 2007;128(5):875–82. doi:10.1309/2YGD1P0QCVCWBLDX. PMID:17951212.
   PubMed Web of Science ®Google Scholar
• Tagaya Y, Gallo RC. The Exceptional Oncogenicity of HTLV-1. Front Microbiol. 2017;8:1425. doi:10.3389/fmicb.2017.01425. PMID:28824561.
   PubMed Web of Science ®Google Scholar
• Ciminale V, Rende F, Bertazzoni U, Romanelli MG. HTLV-1 and HTLV-2: highly similar viruses with distinct oncogenic properties. Front Microbiol. 2014;5:398. doi:10.3389/fmicb.2014.00398. PMID:25120538.
   PubMed Web of Science ®Google Scholar
• Yasuda N, Lai PK, Ip SH, Kung PC, Hinuma Y, Matsuoka M, Hattori T, Takatsuki K, Purtilo D. Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease. Blood. 1988;71(4):1021–6. PMID:2895675.
   PubMed Web of Science ®Google Scholar
• Yamamura M, Yamada Y, Momita S, Kamihira S, Tomonaga M. Circulating interleukin-6 levels are elevated in adult T-cell leukaemia/lymphoma patients and correlate with adverse clinical features and survival. Br. J. Haematol. 1998;100(1):129–34. doi:10.1046/j.1365-2141.1998.00538.x. PMID:9450801.
   PubMed Web of Science ®Google Scholar
• Farre L, Bittencourt AL, Silva-Santos G, Almeida A, Silva AC, Decanine D, Soares GM, Alcantara LC, Jr, Van Dooren S, Galvão-Castro B, et al. Fas 670 promoter polymorphism is associated to susceptibility, clinical presentation, and survival in adult T cell leukemia. J Leukoc Biol. 2008;83(1):220–2. doi:10.1189/jlb.0407198. PMID:17962369.
   PubMed Web of Science ®Google Scholar
• Takeuchi S, Matsushita M, Tsukasaki K, Takeuchi N, Tomonaga M, Komatsu N, Ikezoe T, Uehara Y, Koeffler HP. P53 codon 72 polymorphism is associated with disease progression in adult T-cell leukaemia/lymphoma. Br J Haematol. 2005;131(4):552–3. doi:10.1111/j.1365-2141.2005.05798.x. PMID:16281948.
   PubMed Web of Science ®Google Scholar
• Tamiya S, Etoh K, Suzushima H, Takatsuki K, Matsuoka M. Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells. Blood. 1998;91(10):3935–42. PMID:9573032.
   PubMed Web of Science ®Google Scholar
• Kataoka K, Nagata Y, Kitanaka A, Shiraishi Y, Shimamura T, Yasunaga J, Totoki Y, Chiba K, Sato-Otsubo A, Nagae G, et al. Integrated molecular analysis of adult T cell leukemia/lymphoma. Nat Genet. 2015;47(11):1304–15. doi:10.1038/ng.3415. PMID:26437031.
   PubMed Web of Science ®Google Scholar
• Beltinger C, Kurz E, Böhler T, Schrappe M, Ludwig WD, Debatin KM. CD95 (APO-1/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia. Blood. 1998;91(10):3943–51. PMID:9573033.
   PubMed Web of Science ®Google Scholar
• Huang QR, Morris D, Manolios N. Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene. Mol Immunol. 1997;34(8-9):577–82. doi:10.1016/S0161-5890(97)00081-3. PMID:9393960.
   PubMed Web of Science ®Google Scholar
• Kanemitsu S, Ihara K, Saifddin A, Otsuka T, Takeuchi T, Nagayama J, Kuwano M, Hara T. A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus. J. Rheumatol. 2002;29(6):1183–8. PMID:12064832.
   PubMed Web of Science ®Google Scholar
• Nagai Y, Kawahara M, Hishizawa M, Shimazu Y, Sugino N, Fujii S, Kadowaki N, Takaori-Kondo A. T memory stem cells are the hierarchical apex of adult T-cell leukemia. Blood. 2015;125(23):3527–35. doi:10.1182/blood-2014-10-607465. PMID:25847015.
   PubMed Web of Science ®Google Scholar
• Gill PS, Harrington W, Kaplan MH, Ribeiro RC, Bennett JM, Liebman HA, Bernstein-Singer M, Espina BM, Cabral L, Allen S, et al. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med. 1995;332(26):1744–8. doi:10.1056/NEJM199506293322603. PMID:7760890.
   PubMed Web of Science ®Google Scholar
• Hermine O, Bouscary D, Gessain A, Turlure P, Leblond V, Franck N, Buzyn-Veil A, Rio B, Macintyre E, Dreyfus F, et al. Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N Engl J Med. 1995;332(26):1749–51. doi:10.1056/NEJM199506293322604. PMID:7760891.
   PubMed Web of Science ®Google Scholar
• Bazarbachi A, Plumelle Y, Carlos Ramos J, Tortevoye P, Otrock Z, Taylor G, Gessain A, Harrington W, Panelatti G, Hermine O. Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes. J Clin Oncol. 2010;28(27):4177–83. doi:10.1200/JCO.2010.28.0669. PMID:20585095.
   PubMed Web of Science ®Google Scholar
• Bazarbachi A, Nasr R, El-Sabban ME, Mahé A, Mahieux R, Gessain A, Darwiche N, Dbaibo G, Kersual J, Zermati Y, et al. Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia/lymphoma. Leukemia. 2000;14(4):716–21. doi:10.1038/sj.leu.2401742. PMID:10764160.
   PubMed Web of Science ®Google Scholar
• Moens B, Pannecouque C, López G, Talledo M, Gotuzzo E, Khouri R, Bittencourt A, Farré L, Galvão-Castro B, Vandamme AM, et al. Simultaneous RNA quantification of human and retroviral genomes reveals intact interferon signaling in HTLV-1-infected CD4+ T cell lines. Virol J. 2012;9:171. doi:10.1186/1743-422X-9-171. PMID:22917064.
   PubMed Web of Science ®Google Scholar
• Moens B, Decanine D, Menezes SM, Khouri R, Silva-Santos G, Lopez G, Alvarez C, Talledo M, Gotuzzo E, de Almeida Kruschewsky R, et al. Ascorbic acid has superior ex vivo antiproliferative, cell death-inducing and immunomodulatory effects over IFN-α in HTLV-1-associated myelopathy. PLoS Negl Trop Dis. 2012;6(7):e1729. doi:10.1371/journal.pntd.0001729. PMID:22848768.
   PubMed Web of Science ®Google Scholar
• Smith D, Buckle GJ, Hafler DA, Frank DA, Höllsberg P. HTLV-I-infected T cells evade the antiproliferative action of IFN-beta. Virology. 1999;257(2):314–21. doi:10.1006/viro.1999.9679. PMID:10329542.
   PubMed Web of Science ®Google Scholar
• Dierckx T, Khouri R, Menezes SM, Decanine D, Farre L, Bittencourt A, Vandamme AM, Van Weyenbergh J. IFN-β induces greater antiproliferative and proapoptotic effects and increased p53 signaling compared with IFN-α in PBMCs of Adult T-cell Leukemia/Lymphoma patients. Blood Cancer J. 2017;7(1):e519.25. doi:10.1038/bcj.2016.126..
   Google Scholar
• Kaser A, Nagata S, Tilg H. Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression. Cytokine. 1999;11(10):736–43. doi:10.1006/cyto.1998.0484. PMID:10525311.
   PubMed Web of Science ®Google Scholar
• Van Weyenbergh J, Wietzerbin J, Rouillard D, Barral-Netto M, Liblau R. Treatment of multiple sclerosis patients with interferon-beta primes monocyte-derived macrophages for apoptotic cell death. J Leukoc Biol. 2001;70(5):745–8. PMID:11698494.
   PubMed Web of Science ®Google Scholar
• Gniadek P, Aktas O, Wandinger K-P, Bellmann-Strobl J, Wengert O, Weber A, von Wussow P, Obert HJ, Zipp F. Systemic IFN-beta treatment induces apoptosis of peripheral immune cells in MS patients. J Neuroimmunol. 2003;137(1-2):187–96. doi:10.1016/S0165-5728(03)00074-2. PMID:12667663.
   PubMed Web of Science ®Google Scholar
• Zipp F, Beyer M, Gelderblom H, Wernet D, Zschenderlein R, Weller M. No induction of apoptosis by IFN-beta in human antigen-specific T cells. Neurology. 2000;54(2):485–7. doi:10.1212/WNL.54.2.485. PMID:10668719.
   PubMed Web of Science ®Google Scholar
• Dondi E, Roué G, Yuste VJ, Susin SA, Pellegrini S. A dual role of IFN-alpha in the balance between proliferation and death of human CD4+ T lymphocytes during primary response. J Immunol. 2004;173(6):3740–7. doi:10.4049/jimmunol.173.6.3740. PMID:15356120.
   PubMed Web of Science ®Google Scholar
• Feng X, Vander HN, Ratner L. Alpha interferon inhibits human T-cell leukemia virus type 1 assembly by preventing Gag interaction with rafts. J Virol. 2003;77(24):13389–95. doi:10.1128/JVI.77.24.13389-13395.2003. PMID:14645593.
   PubMed Web of Science ®Google Scholar
• Kiladjian J-J, Giraudier S, Cassinat B. Interferon-alpha for the therapy of myeloproliferative neoplasms: targeting the malignant clone. Leukemia. 2016;30(4):776–81. doi:10.1038/leu.2015.326. PMID:26601783.
   PubMed Web of Science ®Google Scholar
• Mullally A, Bruedigam C, Poveromo L, Heidel FH, Purdon A, Vu T, Austin R, Heckl D, Breyfogle LJ, Kuhn CP, et al. Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera. Blood. 2013;121(18):3692–702. doi:10.1182/blood-2012-05-432989. PMID:23487027.
   PubMed Web of Science ®Google Scholar
• Talpaz M, Mercer J, Hehlmann R. The interferon-alpha revival in CML. Ann. Hematol. 2015;94 Suppl 2:S195–207. doi:10.1007/s00277-015-2326-y. PMID:25814086.
   PubMed Web of Science ®Google Scholar
• Bittencourt AL, Barbosa HS, Requião C, da Silva AC, Vandamme AM, Van Weyenbergh J, Farré L. Adult T-cell leukemia/lymphoma with a mixed CD4+ and CD8+ phenotype and indolent course. J Clin Oncol. 2007;25(17):2480–2. doi:10.1200/JCO.2007.11.3043. PMID:17557960.
   PubMed Web of Science ®Google Scholar
• Farre L, de Oliveira M, de FP, Primo J, Vandamme AM, Van Weyenbergh J, Bittencourt AL. Early sequential development of infective dermatitis, human T cell lymphotropic virus type 1-associated myelopathy, and adult T cell leukemia/lymphoma. Clin Infect Dis. 2008;46(3):440–2. doi:10.1086/524695. PMID:18173359.
   PubMed Web of Science ®Google Scholar
• Moayyeri A, Hammond CJ, Hart DJ, Spector TD. Effects of age on genetic influence on bone loss over 17 years in women: the Healthy Ageing Twin Study (HATS). J Bone Miner Res. 2012;27(10):2170–8. doi:10.1002/jbmr.1659. PMID:22589082.
   PubMed Web of Science ®Google Scholar
• Roederer M, Quaye L, Mangino M, Beddall MH, Mahnke Y, Chattopadhyay P, Tosi I, Napolitano L, Terranova Barberio M, Menni C, et al. The genetic architecture of the human immune system: A bioresource for autoimmunity and disease pathogenesis. Cell. 2015;161(2):387–403. doi:10.1016/j.cell.2015.02.046. PMID:25772697.
   PubMed Web of Science ®Google Scholar
• Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, Quigley MF, Almeida JR, Gostick E, Yu Z, Carpenito C, et al. A human memory T cell subset with stem cell-like properties. Nat Med. 2011;17(10):1290–7. doi:10.1038/nm.2446. PMID:21926977.
   PubMed Web of Science ®Google Scholar
• Kouri V, Khouri R, Alemán Y, Abrahantes Y, Vercauteren J, Pineda-Peña AC, Theys K, Megens S, Moutschen M, Pfeifer N, et al. CRF19_cpx is an Evolutionary fit HIV-1 Variant Strongly Associated With Rapid Progression to AIDS in Cuba. EBioMedicine. 2015;2(3):244–54. doi:10.1016/j.ebiom.2015.01.015. PMID:26137563.
   PubMed Web of Science ®Google Scholar
• Snoek J, Casado C, Colombo S, et al. A Bayesian network approach to study host and viral genetic correlates of HIV-1 disease progression. Retrovirology. 2011;8(Suppl 2):P70. doi:10.1186/1742-4690-8-S2-P70.
   PubMedGoogle Scholar
• Deforche K, Silander T, Camacho R, Grossman Z, Soares MA, Van Laethem K, Kantor R, Moreau Y, Vandamme AM. Analysis of HIV-1 pol sequences using Bayesian Networks: implications for drug resistance. Bioinformatics. 2006;22(24):2975–9. doi:10.1093/bioinformatics/btl508. PMID:17021157.
   PubMed Web of Science ®Google Scholar
• Friedman N, Goldszmidt M, Wyner A. Data Analysis with Bayesian Networks: A Bootstrap Approach. CoRR. 2013;abs–1301–6695. http://dblp.org/rec/bib/journals/corr/abs-1301-6695
   Google Scholar
• Dhein J, Walczak H, Bäumler C, Debatin KM, Krammer PH. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature. 1995;373(6513):438–41. doi:10.1038/373438a0. PMID:7530335.
   PubMed Web of Science ®Google Scholar
• Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature. 1995;373(6513):441–4. doi:10.1038/373441a0. PMID:7530336.
   PubMed Web of Science ®Google Scholar
• Ju ST, Panka DJ, Cui H, Ettinger R, el-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature. 1995;373(6513):444–8. doi:10.1038/373444a0. PMID:7530337.
   PubMed Web of Science ®Google Scholar
• Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–7. doi:10.1038/nmeth.3337. PMID:25822800.
   PubMed Web of Science ®Google Scholar
• Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, Antonenko S, Liu YJ. The nature of the principal type 1 interferon-producing cells in human blood. Science. 1999;284(5421):1835–7. doi:10.1126/science.284.5421.1835. PMID:10364556.
   PubMed Web of Science ®Google Scholar
• Jones KS, Petrow-Sadowski C, Huang YK, Bertolette DC, Ruscetti FW. Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells. Nat Med. 2008;14(4):429–36. doi:10.1038/nm1745. PMID:18376405.
   PubMed Web of Science ®Google Scholar
• Yokote T, Akioka T, Oka S, Hara S, Kobayashi K, Nakajima H, Yamano T, Ikemoto T, Shimizu A, Tsuji M, et al. Flow cytometric immunophenotyping of adult T-cell leukemia/lymphoma using CD3 gating. Am J Clin Pathol. 2005;124(2):199–204. doi:10.1309/KEN4MXM5Y9A1GEMP. PMID:16040289.
   PubMed Web of Science ®Google Scholar
• Tian Y, Kobayashi S, Ohno N, Isobe M, Tsuda M, Zaike Y, Watanabe N, Tani K, Tojo A, Uchimaru K. Leukemic T cells are specifically enriched in a unique CD3(dim) CD7(low) subpopulation of CD4(+) T cells in acute-type adult T-cell leukemia. Cancer Sci. 2011;102(3):569–77. doi:10.1111/j.1349-7006.2010.01833.x. PMID:21205081.
   PubMed Web of Science ®Google Scholar
• Yamano Y, Cohen CJ, Takenouchi N, Yao K, Tomaru U, Li HC, Reiter Y, Jacobson S. Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-I-associated neurologic disease. J Exp Med. 2004;199(10):1367–77. doi:10.1084/jem.20032042. PMID:15136590.
   PubMed Web of Science ®Google Scholar
• Tattermusch S, Skinner JA, Chaussabel D, Banchereau J, Berry MP, McNab FW, O'Garra A, Taylor GP, Bangham CR. Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy. PLoS Pathog. 2012;8(1):e1002480. doi:10.1371/journal.ppat.1002480. PMID:22291590.
   PubMed Web of Science ®Google Scholar
• Dourado I, Alcantara LCJ, Barreto ML, da Gloria Teixeira M, Galvão-Castro B. HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics. J Acquir Immune Defic Syndr. 2003;34(5):527–31. doi:10.1097/00126334-200312150-00013. PMID:14657765.
   PubMed Web of Science ®Google Scholar
• Sun T, Zhou Y, Li H, Han X, Shi Y, Wang L, Miao X, Tan W, Zhao D, Zhang X, et al. FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. J. Exp. Med. 2005;202(7):967–74. doi:10.1084/jem.20050707. PMID:16186185.
   PubMed Web of Science ®Google Scholar
• Paulsen M, Valentin S, Mathew B, Adam-Klages S, Bertsch U, Lavrik I, Krammer PH, Kabelitz D, Janssen O. Modulation of CD4+ T-cell activation by CD95 co-stimulation. Cell Death Differ. 2011;18(4):619–31. doi:10.1038/cdd.2010.134. PMID:21052094.
   PubMed Web of Science ®Google Scholar
• Klebanoff CA, Scott CD, Leonardi AJ, Yamamoto TN, Cruz AC, Ouyang C, Ramaswamy M, Roychoudhuri R, Ji Y, Eil RL, et al. Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy. J Clin Invest. 2016;126(1):318–34. doi:10.1172/JCI81217. PMID:26657860.
   PubMed Web of Science ®Google Scholar
• Menezes SM, Leal FE, Dierckx T, Khouri R, Decanine D, Silva-Santos G, Schnitman SV, Kruschewsky R, López G, Alvarez C, et al. A Fas(hi) Lymphoproliferative Phenotype Reveals Non-Apoptotic Fas Signaling in HTLV-1-Associated Neuroinflammation. Front Immunol. 2017;8:97. doi:10.3389/fimmu.2017.00097. PMID:28261198.
   PubMed Web of Science ®Google Scholar
• Debatin KM, Goldman CK, Waldmann TA, Krammer PH. APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood. 1993;81(11):2972–7. PMID:7684622.
   PubMed Web of Science ®Google Scholar
• Strauss G, Knape I, Melzner I, Debatin K-M. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells. J. Immunol. 2003;171(3):1172–82. doi:10.4049/jimmunol.171.3.1172. PMID:12874203.
   PubMed Web of Science ®Google Scholar
• Krueger A, Fas SC, Giaisi M, Bleumink M, Merling A, Stumpf C, Baumann S, Holtkotte D, Bosch V, Krammer PH, et al. HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP). Blood. 2006;107(10):3933–9. doi:10.1182/blood-2005-06-2567. PMID:16403915.
   PubMed Web of Science ®Google Scholar
• Zane L, Sibon D, Legras C, Lachuer J, Wierinckx A, Mehlen P, Delfau-Larue MH, Gessain A, Gout O, Pinatel C, et al. Clonal expansion of HTLV-1 positive CD8+ cells relies on cIAP-2 but not on c-FLIP expression. Virology. 2010;407(2):341–51. doi:10.1016/j.virol.2010.07.023. PMID:20863547.
   PubMed Web of Science ®Google Scholar
• Chen L, Park S-M, Tumanov AV, Hau A, Sawada K, Feig C, Turner JR, Fu YX, Romero IL, Lengyel E, et al. CD95 promotes tumour growth. Nature. 2010;465(7297):492–6. doi:10.1038/nature09075. PMID:20505730.
   PubMed Web of Science ®Google Scholar
• Toulza F, Heaps A, Tanaka Y, Taylor GP, Bangham CRM. High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response. Blood. 2008;111(10):5047–53. doi:10.1182/blood-2007-10-118539. PMID:18094326.
   PubMed Web of Science ®Google Scholar
• Sibley K, Rollinson S, Allan JM, Smith AG, Law GR, Roddam PL, Skibola CF, Smith MT, Morgan GJ. Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia. Cancer Res. 2003;63(15):4327–30. PMID:12907599.
   PubMed Web of Science ®Google Scholar
• Sibon D, Gabet A-S, Zandecki M, Pinatel C, Thête J, Delfau-Larue MH, Rabaaoui S, Gessain A, Gout O, Jacobson S, et al. HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death. J Clin Invest. 2006;116(4):974–83. doi:10.1172/JCI27198. PMID:16585963.
   PubMed Web of Science ®Google Scholar
• Enose-Akahata Y, Oh U, Grant C, Jacobson S. Retrovirally induced CTL degranulation mediated by IL-15 expression and infection of mononuclear phagocytes in patients with HTLV-I-associated neurologic disease. Blood. 2008;112(6):2400–10. doi:10.1182/blood-2008-02-138529. PMID:18509087.
   PubMed Web of Science ®Google Scholar
• Norris PJ, Hirschkorn DF, DeVita DA, Lee TH, Murphy EL. Human T cell leukemia virus type 1 infection drives spontaneous proliferation of natural killer cells. Virulence. 2010;1(1):19–28. doi:10.4161/viru.1.1.9868. PMID:20640055.
   PubMed Web of Science ®Google Scholar